TABLE 4.
Organism | MIC (μg/ml)b of the following antibioticc for the indicated organism:
|
|||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Amp | Clo | Pen | Van | Kan | Neo | Par | Str | Chl | Ery | Tet | Nis | |
B. animalis ATCC 27536 | 0.98 | 125 | 0.98 | 1.9 | 500 | 125 | 125 | 125 | 1.9 | 1.9 | 125 | 0.98 |
B. bifidum R 0071 | 0.98 | 62.5 | 0.98 | >500 | 500 | 62.5 | 125 | 125 | 3.9 | 3.9 | 62.5 | 0.98 |
B. bifidum ATCC 15696 | 0.98 | 62.5 | 0.98 | >500 | 125 | 250 | 500 | 1.9 | 3.9 | 3.9 | 125 | 0.98 |
B. bifidum BB12 | 0.98 | 1.9 | 0.98 | >500 | 500 | 250 | 250 | 500 | 1.9 | 3.9 | 3.9 | 3.9 |
B. breve ATCC 15700 | 3.9 | 3.9 | 0.98 | >500 | 500 | 125 | 250 | 250 | 3.9 | 0.98 | 31.2 | 0.98 |
B. breve R0070 | 0.98 | 31.2 | 0.98 | >500 | 500 | 62.5 | 125 | 125 | 3.9 | 0.98 | 62.5 | 0.98 |
B. infantis ATCC 15697 | 0.98 | 125 | 0.98 | 0.98 | >500 | 500 | 500 | 250 | 0.98 | 3.9 | 250 | 3.9 |
B. longum ATCC 15707 | 0.98 | 125 | 0.98 | >500 | 250 | 125 | 125 | 62.5 | 1.9 | 3.9 | 125 | 0.98 |
B. longum ATCC 15708 | 0.98 | 125 | 0.98 | 0.98 | 500 | 500 | 500 | 250 | 0.98 | 1.9 | 125 | 0.98 |
B. longum R0175 | 0.98 | 125 | 0.98 | >500 | 500 | 62.5 | 125 | 125 | 1.9 | 1.9 | 125 | 3.9 |
B. longum P/N 601377 | 0.98 | 62.5 | 0.98 | >500 | 250 | 62.5 | 62.5 | 125 | 1.9 | 3.9 | 62.5 | 3.9 |
B. pseudolongum ATCC 25562 | 0.98 | 62.5 | 0.98 | 0.98 | 500 | 250 | 500 | 250 | 0.98 | 3.9 | 125 | 0.98 |
B. thermophilum ATCC 25866 | 1.9 | 62.5 | 0.98 | >500 | 500 | 125 | 250 | 250 | 3.9 | 3.9 | 125 | 0.98 |
Organisms were exposed to 0.3% (wt/vol) oxgall for 90 min prior to 18 h of anaerobic growth in MRS broth, pH 6.5.
Median of four repetitions.
Amp, ampicillin; Clo, cloxacillin; Pen, penicillin G; Van, vancomycin; Kan, kanamycin; Neo, neomycin; Par, paromomycin; Str, streptomycin; Chl, chloramphenicol; Ery, erythromycin; Tet, tetracycline hydrochloride; Nis, nisin A.